• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

空气冷却止痛对原卟啉 IX 光漂白和皮肤病光动力治疗临床疗效的影响。

The effect of air cooling pain relief on protoporphyrin IX photobleaching and clinical efficacy during dermatological photodynamic therapy.

机构信息

Clinical Photobiology, European Centre for Environment and Human Health, Peninsula Medical School, University of Exeter, Knowledge Spa, Royal Cornwall Hospital, Truro, Cornwall TR1 3HD, UK.

出版信息

J Photochem Photobiol B. 2011 Apr 4;103(1):1-7. doi: 10.1016/j.jphotobiol.2010.12.011. Epub 2010 Dec 28.

DOI:10.1016/j.jphotobiol.2010.12.011
PMID:21277787
Abstract

Methyl aminolevulinate photodynamic therapy (MAL-PDT) is utilized to successfully treat licensed indications (e.g. actinic keratosis (AK), superficial basal cell carcinoma (sBCC) and Bowen's disease (BD)) in the UK. Air cooling devices (ACD) are commonly utilized as a method of pain relief, however the effect of this on treatment outcome has never been extensively investigated. This non-randomized, retrospective observational controlled study investigated whether the application of the ACD limited photosensitiser (protoporphyrin IX - PpIX) photobleaching during irradiation and/or subsequent clinical outcome. Patients utilizing the ACD throughout treatment were observed to undergo significantly less PpIX photobleaching than the control group (P<0.001) and complete clinical clearances observed at 3 months were also reduced within the ACD group. Separate analysis of the different lesion types indicated that significantly less photobleaching occurred in AK lesions with ACD and all lesion types failed to fully utilize the accumulated PpIX when ACD was employed. The application of the ACD as pain relief during light irradiation therefore resulted in lower PpIX photobleaching which corresponded to a reduction in the efficacy of PDT treatment. Whilst the ACD is an effective method of dermatological PDT analgesia it should be utilized as sparingly as possible to minimize any deleterious effects on treatment outcome.

摘要

甲氨基酮戊酸光动力疗法 (MAL-PDT) 在英国被用于成功治疗有适应证的疾病(如光化性角化病 (AK)、浅表基底细胞癌 (sBCC) 和 Bowen 病 (BD))。空气冷却设备 (ACD) 通常被用作缓解疼痛的方法,但其对治疗效果的影响从未被广泛研究过。这项非随机、回顾性观察性对照研究调查了 ACD 的应用是否限制了照射期间的光敏剂(原卟啉 IX - PpIX)光漂白和/或随后的临床结果。观察到在整个治疗过程中使用 ACD 的患者经历的 PpIX 光漂白明显少于对照组(P<0.001),并且在 ACD 组中,也降低了 3 个月时完全临床清除的发生率。对不同病变类型的单独分析表明,在 AK 病变中,ACD 下发生的光漂白明显减少,当使用 ACD 时,所有病变类型都未能充分利用积累的 PpIX。因此,在光照射期间使用 ACD 缓解疼痛会导致 PpIX 光漂白减少,这对应于 PDT 治疗效果的降低。尽管 ACD 是一种有效的皮肤科 PDT 镇痛方法,但应尽可能少地使用它,以尽量减少对治疗效果的任何有害影响。

相似文献

1
The effect of air cooling pain relief on protoporphyrin IX photobleaching and clinical efficacy during dermatological photodynamic therapy.空气冷却止痛对原卟啉 IX 光漂白和皮肤病光动力治疗临床疗效的影响。
J Photochem Photobiol B. 2011 Apr 4;103(1):1-7. doi: 10.1016/j.jphotobiol.2010.12.011. Epub 2010 Dec 28.
2
The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.实时皮肤氨基酮戊酸光动力疗法(MAL-PDT)期间原卟啉IX光漂白与后续临床结果之间的关系。
Lasers Surg Med. 2010 Sep;42(7):613-9. doi: 10.1002/lsm.20943.
3
Regression Analysis of Protoporphyrin IX Measurements Obtained During Dermatological Photodynamic Therapy.皮肤科光动力治疗期间获得的原卟啉IX测量值的回归分析
Cancers (Basel). 2019 Jan 10;11(1):72. doi: 10.3390/cancers11010072.
4
Protoporphyrin IX photobleaching during the light irradiation phase of standard dermatological methyl-aminolevulinate photodynamic therapy.在标准皮肤科氨甲酰基-L- 丙氨酸光动力疗法的光照阶段中,原卟啉 IX 光漂白。
Photodiagnosis Photodyn Ther. 2010 Dec;7(4):232-8. doi: 10.1016/j.pdpdt.2010.09.005. Epub 2010 Nov 5.
5
Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification.利用无创荧光成像和定量技术监测标准皮肤科氨甲酰基乙酸甲酯光动力疗法中光敏剂原卟啉 IX 的积累和消散。
Photodiagnosis Photodyn Ther. 2011 Mar;8(1):30-8. doi: 10.1016/j.pdpdt.2010.11.001. Epub 2010 Dec 17.
6
The effects of protoporphyrin IX-induced photodynamic therapy with and without iron chelation on human squamous carcinoma cells cultured under normoxic, hypoxic and hyperoxic conditions.原卟啉 IX 诱导的光动力疗法联合与不联合铁螯合作用对常氧、低氧和高氧条件下培养的人鳞状癌细胞的影响。
Photodiagnosis Photodyn Ther. 2013 Dec;10(4):575-82. doi: 10.1016/j.pdpdt.2013.06.006. Epub 2013 Aug 8.
7
A quantitative comparison of 5-aminolaevulinic acid- and methyl aminolevulinate-induced fluorescence, photobleaching and pain during photodynamic therapy.5-氨基酮戊酸和甲氨基酮戊酸诱导的光动力疗法中的荧光、光漂白和疼痛的定量比较。
Photochem Photobiol. 2011 Jan-Feb;87(1):242-9. doi: 10.1111/j.1751-1097.2010.00829.x. Epub 2010 Nov 15.
8
Correlation between treatment time, photobleaching, inflammation and pain after photodynamic therapy with methyl aminolevulinate on tape-stripped skin in healthy volunteers.在健康志愿者的胶带剥离皮肤上,用氨基乙酰丙酸甲酯进行光动力治疗后,治疗时间、光漂白、炎症与疼痛之间的相关性。
Photochem Photobiol Sci. 2015 May;14(5):875-82. doi: 10.1039/c5pp00069f.
9
Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites.比较肢端和非肢端部位皮肤肿瘤在甲氨基酮戊酸光动力疗法中卟啉IX 的积累和破坏。
Br J Dermatol. 2011 Jun;164(6):1362-8. doi: 10.1111/j.1365-2133.2011.10265.x. Epub 2011 May 13.
10
Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome.不同光通量率下光动力疗法治疗光化性角化病:光漂白、疼痛及主要临床结果评估
Br J Dermatol. 2004 Dec;151(6):1204-12. doi: 10.1111/j.1365-2133.2004.06211.x.

引用本文的文献

1
Nanoparticle-Mediated Photothermal Therapy Limitation in Clinical Applications Regarding Pain Management.纳米颗粒介导的光热疗法在疼痛管理临床应用中的局限性
Nanomaterials (Basel). 2022 Mar 10;12(6):922. doi: 10.3390/nano12060922.
2
Photodynamic Therapy for Basal Cell Carcinoma: The Clinical Context for Future Research Priorities.光动力疗法治疗基底细胞癌:未来研究重点的临床背景。
Molecules. 2020 Nov 18;25(22):5398. doi: 10.3390/molecules25225398.
3
Smartphone fluorescence imager for quantitative dosimetry of protoporphyrin-IX-based photodynamic therapy in skin.
智能手机荧光成像仪定量测定皮肤中基于原卟啉 IX 的光动力疗法。
J Biomed Opt. 2019 Dec;25(6):1-13. doi: 10.1117/1.JBO.25.6.063802.
4
A New Light-Emitting, Fabric-Based Device for Photodynamic Therapy of Actinic Keratosis: Protocol for a Randomized, Controlled, Multicenter, Intra-Individual, Phase II Noninferiority Study (the Phosistos Study).一种用于光化性角化病光动力治疗的新型发光织物基装置:一项随机、对照、多中心、个体内、II期非劣效性研究方案(Phosistos研究)
JMIR Res Protoc. 2019 Apr 26;8(4):e12990. doi: 10.2196/12990.
5
Regression Analysis of Protoporphyrin IX Measurements Obtained During Dermatological Photodynamic Therapy.皮肤科光动力治疗期间获得的原卟啉IX测量值的回归分析
Cancers (Basel). 2019 Jan 10;11(1):72. doi: 10.3390/cancers11010072.
6
In-office Painless Aminolevulinic Acid Photodynamic Therapy: A Proof of Concept Study and Clinical Experience in More Than 100 Patients.门诊无痛氨基乙酰丙酸光动力疗法:一项概念验证研究及100余例患者的临床经验
J Clin Aesthet Dermatol. 2016 Feb;9(2):19-26.
7
Pre-treatment protoporphyrin IX concentration in actinic keratosis lesions may be a predictive biomarker of response to aminolevulinic-acid based photodynamic therapy.光化性角化病皮损的治疗前原卟啉IX浓度可能是基于氨基乙酰丙酸的光动力疗法反应的预测生物标志物。
Photodiagnosis Photodyn Ther. 2015 Dec;12(4):561-6. doi: 10.1016/j.pdpdt.2015.10.006. Epub 2015 Oct 22.